Central Bank & Trust’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Central Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-340	Closed	-$16K	–	338
2016 Q3	$16K	Hold	340	–	–	﹤0.01%	234
2016 Q2	$17K	Hold	340	–	–	﹤0.01%	235
2016 Q1	$18K	Buy	340 +100	+42%	+$5.87K	0.01%	243
2015 Q4	$16K	Hold	240	–	–	﹤0.01%	256
2015 Q3	$14K	Hold	240	–	–	﹤0.01%	277
2015 Q2	$14K	Hold	240	–	–	﹤0.01%	258
2015 Q1	$15K	Hold	240	–	–	0.01%	254
2014 Q4	$14K	Hold	240	–	–	﹤0.01%	260
2014 Q3	$13K	Buy	+240	New	+$12.7K	﹤0.01%	233

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Central Bank & Trust's TEVA Position: Q4 2016 in Review

Central Bank & Trust sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 340 shares — an estimated $16K sold.

Central Bank & Trust first reported a position in TEVA in Q3 2014 and held it in 9 quarters. The position peaked at $18K in Q1 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Central Bank & Trust reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
Central Bank & Trust sold 340 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $16K.
Central Bank & Trust first reported a position in Teva Pharmaceutical Industries Limited in Q3 2014 and held it in 9 quarters.
Central Bank & Trust's Teva Pharmaceutical Industries Limited position peaked at $18K in Q1 2016.
739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on Central Bank & Trust's 13F filing for Q4 2016, filed 20 Jan 2017.